4
Changes in Ownership
Enveric Biosciences, Inc. Filed Acc 0000921895-18-002602
Options or other derivatives
- Chief Executive Officer acquired 250,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Kelton Brent Chief Executive Officer | 2018-09-12 | Grant or award · Option (Right to Buy) | +250,000 | 250,000 | D | ||
Loading xslF345X03/form410211002kel_09142018.xml…